Skip to main content
Top

06-09-2024 | Dementia | Neurology and Preclinical Neurological Studies - Review Article

Behavioral disorders in dementia with Lewy bodies: old and new knowledge

Author: Kurt A. Jellinger

Published in: Journal of Neural Transmission

Login to get access

Abstract

Dementia with Lewy bodies (DLB), the second most common primary degenerative neurocognitive disorder after Alzheimer disease, is frequently preceded by REM sleep behavior disorders (RBD) and other behavioral symptoms, like anxiety, irritability, agitation or apathy, as well as visual hallucinations and delusions, most of which occurring in 40–60% of DLB patients. Other frequent behavioral symptoms like attention deficits contribute to cognitive impairment, while attention-deficit/hyperactivity disorder (ADHD) is a risk factor for DLB. Behavioral problems in DLB are more frequent, more severe and appear earlier than in other neurodegenerative diseases and, together with other neuropsychiatric symptoms, contribute to impairment of quality of life of the patients, but their pathophysiology is poorly understood. Neuroimaging studies displayed deficits in cholinergic brainstem nuclei and decreased metabolism in frontal, superior parietal regions, cingulate gyrus and amygdala in DLB. Early RBD in autopsy-confirmed DLB is associated with lower Braak neuritic stages, whereas those without RBD has greater atrophy of hippocampus and increased tau burden. αSyn pathology in the amygdala, a central region in the fear circuitry, may contribute to the high prevalence of anxiety, while in attention dysfunctions the default mode and dorsal attention networks displayed diverging activity. These changes suggest that behavioral disorders in DLB are associated with marked impairment in large-scale brain structures and functional connectivity network disruptions. However, many pathobiological mechanisms involved in the development of behavioral disorders in DLB await further elucidation in order to allow an early diagnosis and adequate treatment to prevent progression of these debilitating disorders.
Literature
go back to reference American Psychiatric Association (2013) Diagnostic and statistical Manual of Mental disorders 5th Ed. (DSM–5). American Psychiatric Publishing, Arlington, VACrossRef American Psychiatric Association (2013) Diagnostic and statistical Manual of Mental disorders 5th Ed. (DSM–5). American Psychiatric Publishing, Arlington, VACrossRef
go back to reference Armstrong MJ, LaBarre B, Sovich K, Maixner SM, Paulson HL, Manning C, Fields JA, Lunde A, Forsberg L, Boeve BF, Galvin JE, Taylor AS, Li Z (2024) Patient- and proxy-reported quality of life in advanced dementia with Lewy bodies. Alzheimers Dement 20:2719–2730PubMedPubMedCentralCrossRef Armstrong MJ, LaBarre B, Sovich K, Maixner SM, Paulson HL, Manning C, Fields JA, Lunde A, Forsberg L, Boeve BF, Galvin JE, Taylor AS, Li Z (2024) Patient- and proxy-reported quality of life in advanced dementia with Lewy bodies. Alzheimers Dement 20:2719–2730PubMedPubMedCentralCrossRef
go back to reference Arnaldi D, Mattioli P, Raffa S, Pardini M, Massa F, Iranzo A, Perissinotti A, Niñerola-Baizán A, Gaig C, Serradell M, Muñoz-Lopetegi A, Mayà G, Liguori C, Fernandes M, Placidi F, Chiaravalloti A, Šonka K, Dušek P, Zogala D, Trnka J, Boeve BF, Miyagawa T, Lowe VJ, Miyamoto T, Miyamoto M, Puligheddu M, Figorilli M, Serra A, Hu MT, Klein JC, Bes F, Kunz D, De Cochen V, de Verbizier D, Plazzi G, Antelmi E, Terzaghi M, Bossert I, Kulcsárová K, Martino A, Giuliani A, Pagani M, Nobili F, Morbelli S (2024) Presynaptic dopaminergic imaging characterizes patients with REM sleep behavior disorder due to synucleinopathy. Ann Neurol 95:1178–1192PubMedCrossRef Arnaldi D, Mattioli P, Raffa S, Pardini M, Massa F, Iranzo A, Perissinotti A, Niñerola-Baizán A, Gaig C, Serradell M, Muñoz-Lopetegi A, Mayà G, Liguori C, Fernandes M, Placidi F, Chiaravalloti A, Šonka K, Dušek P, Zogala D, Trnka J, Boeve BF, Miyagawa T, Lowe VJ, Miyamoto T, Miyamoto M, Puligheddu M, Figorilli M, Serra A, Hu MT, Klein JC, Bes F, Kunz D, De Cochen V, de Verbizier D, Plazzi G, Antelmi E, Terzaghi M, Bossert I, Kulcsárová K, Martino A, Giuliani A, Pagani M, Nobili F, Morbelli S (2024) Presynaptic dopaminergic imaging characterizes patients with REM sleep behavior disorder due to synucleinopathy. Ann Neurol 95:1178–1192PubMedCrossRef
go back to reference Arnaldo L, Urbizu A, Serradell M, Gaig C, Anillo A, Gea M, Vilas D, Ispierto L, Muñoz-Lopetegi A, Mayà G, Pastor P, Álvarez R, Santamaria J, Iranzo A, Beyer K (2023) Peripheral alpha-synuclein isoforms are potential biomarkers for diagnosis and prognosis of isolated REM sleep behavior disorder. Parkinsonism Relat Disord 115:105832PubMedCrossRef Arnaldo L, Urbizu A, Serradell M, Gaig C, Anillo A, Gea M, Vilas D, Ispierto L, Muñoz-Lopetegi A, Mayà G, Pastor P, Álvarez R, Santamaria J, Iranzo A, Beyer K (2023) Peripheral alpha-synuclein isoforms are potential biomarkers for diagnosis and prognosis of isolated REM sleep behavior disorder. Parkinsonism Relat Disord 115:105832PubMedCrossRef
go back to reference Ballard C, O’Brien J, Gray A, Cormack F, Ayre G, Rowan E, Thompson P, Bucks R, McKeith I, Walker M, Tovee M (2001) Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol 58:977–982PubMedCrossRef Ballard C, O’Brien J, Gray A, Cormack F, Ayre G, Rowan E, Thompson P, Bucks R, McKeith I, Walker M, Tovee M (2001) Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol 58:977–982PubMedCrossRef
go back to reference Becker S, Chowdhury M, Tavilsup P, Seitz D, Callahan BL (2023) Risk of neurodegenerative disease or dementia in adults with attention-deficit/hyperactivity disorder: a systematic review. Front Psychiatry 14:1158546PubMedPubMedCentralCrossRef Becker S, Chowdhury M, Tavilsup P, Seitz D, Callahan BL (2023) Risk of neurodegenerative disease or dementia in adults with attention-deficit/hyperactivity disorder: a systematic review. Front Psychiatry 14:1158546PubMedPubMedCentralCrossRef
go back to reference Bedard MA, Aghourian M, Legault-Denis C, Postuma RB, Soucy JP, Gagnon JF, Pelletier A, Montplaisir J (2019) Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with (18)F-FEOBV. Sleep Med 58:35–41PubMedCrossRef Bedard MA, Aghourian M, Legault-Denis C, Postuma RB, Soucy JP, Gagnon JF, Pelletier A, Montplaisir J (2019) Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with (18)F-FEOBV. Sleep Med 58:35–41PubMedCrossRef
go back to reference Bjoerke-Bertheussen J, Ehrt U, Rongve A, Ballard C, Aarsland D (2012) Neuropsychiatric symptoms in mild dementia with lewy bodies and Alzheimer’s disease. Dement Geriatr Cogn Disord 34:1–6PubMedCrossRef Bjoerke-Bertheussen J, Ehrt U, Rongve A, Ballard C, Aarsland D (2012) Neuropsychiatric symptoms in mild dementia with lewy bodies and Alzheimer’s disease. Dement Geriatr Cogn Disord 34:1–6PubMedCrossRef
go back to reference Blanc F, Bouteloup V, Paquet C, Chupin M, Pasquier F, Gabelle A, Ceccaldi M, de Sousa PL, Krolak-Salmon P, David R, Fischer C, Dartigues JF, Wallon D, Moreaud O, Sauvée M, Belin C, Harston S, Botzung A, Albasser T, Demuynck C, Namer I, Habert MO, Kremer S, Bousiges O, Verny M, Muller C, Philippi N, Chene G, Cretin B, Mangin JF, Dufouil C (2022) Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort. Alzheimers Res Ther 14:96PubMedPubMedCentralCrossRef Blanc F, Bouteloup V, Paquet C, Chupin M, Pasquier F, Gabelle A, Ceccaldi M, de Sousa PL, Krolak-Salmon P, David R, Fischer C, Dartigues JF, Wallon D, Moreaud O, Sauvée M, Belin C, Harston S, Botzung A, Albasser T, Demuynck C, Namer I, Habert MO, Kremer S, Bousiges O, Verny M, Muller C, Philippi N, Chene G, Cretin B, Mangin JF, Dufouil C (2022) Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort. Alzheimers Res Ther 14:96PubMedPubMedCentralCrossRef
go back to reference Boeve BF, Silber MH, Ferman TJ (2004) REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17:146–157PubMedCrossRef Boeve BF, Silber MH, Ferman TJ (2004) REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17:146–157PubMedCrossRef
go back to reference Borda MG, Brønnick KK, Garcia-Cifuentes E, Jaramillo-Jimenez A, Reyes-Ortiz C, Patricio-Baldera J, Soennesyn H, Pérez-Zepeda MU, Vik-Mo AO, Aarsland D (2023) Specific neuropsychiatric symptoms are associated with functional decline trajectories in Alzheimer’s disease and Lewy body dementia: a five-year follow-up study. Front Med (Lausanne) 10:1267060PubMedCrossRef Borda MG, Brønnick KK, Garcia-Cifuentes E, Jaramillo-Jimenez A, Reyes-Ortiz C, Patricio-Baldera J, Soennesyn H, Pérez-Zepeda MU, Vik-Mo AO, Aarsland D (2023) Specific neuropsychiatric symptoms are associated with functional decline trajectories in Alzheimer’s disease and Lewy body dementia: a five-year follow-up study. Front Med (Lausanne) 10:1267060PubMedCrossRef
go back to reference Borroni B, Agosti C, Padovani A (2008a) Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment. Arch Gerontol Geriatr 46:101–106PubMedCrossRef Borroni B, Agosti C, Padovani A (2008a) Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment. Arch Gerontol Geriatr 46:101–106PubMedCrossRef
go back to reference Borroni B, Turla M, Bertasi V, Agosti C, Gilberti N, Padovani A (2008b) Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. Arch Gerontol Geriatr 47:53–61PubMedCrossRef Borroni B, Turla M, Bertasi V, Agosti C, Gilberti N, Padovani A (2008b) Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. Arch Gerontol Geriatr 47:53–61PubMedCrossRef
go back to reference Boutros SW, Raber J, Unni VK (2021) Effects of alpha-synuclein targeted antisense oligonucleotides on Lewy body-like pathology and behavioral disturbances induced by injections of pre-formed fibrils in the mouse motor cortex. J Parkinsons Dis 11:1091–1115PubMedPubMedCentralCrossRef Boutros SW, Raber J, Unni VK (2021) Effects of alpha-synuclein targeted antisense oligonucleotides on Lewy body-like pathology and behavioral disturbances induced by injections of pre-formed fibrils in the mouse motor cortex. J Parkinsons Dis 11:1091–1115PubMedPubMedCentralCrossRef
go back to reference Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL (2003) Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 11:214–221PubMedCrossRef Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL (2003) Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 11:214–221PubMedCrossRef
go back to reference Bradshaw JM, Saling M, Anderson V, Hopwood M, Brodtmann A (2006) Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer’s type and controls. J Neurol Neurosurg Psychiatry 77:1129–1135PubMedPubMedCentralCrossRef Bradshaw JM, Saling M, Anderson V, Hopwood M, Brodtmann A (2006) Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer’s type and controls. J Neurol Neurosurg Psychiatry 77:1129–1135PubMedPubMedCentralCrossRef
go back to reference Breitve MH, Hynninen MJ, Brønnick K, Chwiszczuk LJ, Auestad BH, Aarsland D, Rongve A (2016) A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer’s disease. Alzheimers Res Ther 8:3PubMedPubMedCentralCrossRef Breitve MH, Hynninen MJ, Brønnick K, Chwiszczuk LJ, Auestad BH, Aarsland D, Rongve A (2016) A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer’s disease. Alzheimers Res Ther 8:3PubMedPubMedCentralCrossRef
go back to reference Breitve MH, Brønnick K, Chwiszczuk LJ, Hynninen MJ, Aarsland D, Rongve A (2018) Apathy is associated with faster global cognitive decline and early nursing home admission in dementia with Lewy bodies. Alzheimers Res Ther 10:83PubMedPubMedCentralCrossRef Breitve MH, Brønnick K, Chwiszczuk LJ, Hynninen MJ, Aarsland D, Rongve A (2018) Apathy is associated with faster global cognitive decline and early nursing home admission in dementia with Lewy bodies. Alzheimers Res Ther 10:83PubMedPubMedCentralCrossRef
go back to reference Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D (2019) Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimers Res Ther 11:20PubMedPubMedCentralCrossRef Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D (2019) Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimers Res Ther 11:20PubMedPubMedCentralCrossRef
go back to reference Carr RH, Eom GD, Brown EE (2024) Attention-deficit/hyperactivity disorder as a potential risk factor for dementia and other neurocognitive disorders: a systematic review. J Alzheimers Dis 98:773–792PubMedCrossRef Carr RH, Eom GD, Brown EE (2024) Attention-deficit/hyperactivity disorder as a potential risk factor for dementia and other neurocognitive disorders: a systematic review. J Alzheimers Dis 98:773–792PubMedCrossRef
go back to reference Chan PC, Lee HH, Hong CT, Hu CJ, Wu D (2018) REM sleep behavior disorder (RBD) in dementia with Lewy bodies (DLB). Behav Neurol 2018:9421098 Chan PC, Lee HH, Hong CT, Hu CJ, Wu D (2018) REM sleep behavior disorder (RBD) in dementia with Lewy bodies (DLB). Behav Neurol 2018:9421098
go back to reference Cromarty RA, Schumacher J, Graziadio S, Gallagher P, Killen A, Firbank MJ, Blamire A, Kaiser M, Thomas AJ, O’Brien JT, Peraza LR, Taylor JP (2018) Structural brain correlates of attention dysfunction in Lewy body dementias and Alzheimer’s disease. Front Aging Neurosci 10:347PubMedPubMedCentralCrossRef Cromarty RA, Schumacher J, Graziadio S, Gallagher P, Killen A, Firbank MJ, Blamire A, Kaiser M, Thomas AJ, O’Brien JT, Peraza LR, Taylor JP (2018) Structural brain correlates of attention dysfunction in Lewy body dementias and Alzheimer’s disease. Front Aging Neurosci 10:347PubMedPubMedCentralCrossRef
go back to reference Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314PubMedCrossRef Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314PubMedCrossRef
go back to reference Cummings J, Lai TJ, Hemrungrojn S, Mohandas E, Yun Kim S, Nair G, Dash A (2016) Role of donepezil in the management of neuropsychiatric symptoms in Alzheimer’s disease and dementia with Lewy bodies. CNS Neurosci Ther 22:159–166PubMedPubMedCentralCrossRef Cummings J, Lai TJ, Hemrungrojn S, Mohandas E, Yun Kim S, Nair G, Dash A (2016) Role of donepezil in the management of neuropsychiatric symptoms in Alzheimer’s disease and dementia with Lewy bodies. CNS Neurosci Ther 22:159–166PubMedPubMedCentralCrossRef
go back to reference de Oliveira FF, Miraldo MC, de Castro-Neto EF, de Almeida SS, Matas SLA, Bertolucci PHF, Naffah-Mazzacoratti MDG (2021) Associations of neuropsychiatric features with cerebrospinal fluid biomarkers of amyloidogenesis and neurodegeneration in dementia with Lewy bodies compared with Alzheimer’s disease and cognitively healthy people. J Alzheimers Dis 81:1295–1309PubMedCrossRef de Oliveira FF, Miraldo MC, de Castro-Neto EF, de Almeida SS, Matas SLA, Bertolucci PHF, Naffah-Mazzacoratti MDG (2021) Associations of neuropsychiatric features with cerebrospinal fluid biomarkers of amyloidogenesis and neurodegeneration in dementia with Lewy bodies compared with Alzheimer’s disease and cognitively healthy people. J Alzheimers Dis 81:1295–1309PubMedCrossRef
go back to reference de Oliveira FF, Miraldo MC, de Castro-Neto EF, de Almeida SS, Matas SLA, Bertolucci PHF, Naffah-Mazzacoratti MDG (2023) Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer’s disease. Aging Clin Exp Res 35:1741–1752PubMedCrossRef de Oliveira FF, Miraldo MC, de Castro-Neto EF, de Almeida SS, Matas SLA, Bertolucci PHF, Naffah-Mazzacoratti MDG (2023) Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer’s disease. Aging Clin Exp Res 35:1741–1752PubMedCrossRef
go back to reference Dodel R, Berg D, Duning T, Kalbe E, Meyer PT, Ramirez A, Storch A, Aarsland D, Jessen F (2024) [Dementia with Lewy bodies: old and new knowledge-part 2: treatment]. Nervenarzt 95:362–367PubMedCrossRef Dodel R, Berg D, Duning T, Kalbe E, Meyer PT, Ramirez A, Storch A, Aarsland D, Jessen F (2024) [Dementia with Lewy bodies: old and new knowledge-part 2: treatment]. Nervenarzt 95:362–367PubMedCrossRef
go back to reference Donaghy PC, Taylor JP, O’Brien JT, Barnett N, Olsen K, Colloby SJ, Lloyd J, Petrides G, McKeith IG, Thomas AJ (2018) Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies. Psychol Med 48:2384–2390PubMedCrossRef Donaghy PC, Taylor JP, O’Brien JT, Barnett N, Olsen K, Colloby SJ, Lloyd J, Petrides G, McKeith IG, Thomas AJ (2018) Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies. Psychol Med 48:2384–2390PubMedCrossRef
go back to reference Dugger BN, Boeve BF, Murray ME, Parisi JE, Fujishiro H, Dickson DW, Ferman TJ (2012a) Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies. Mov Disord 27:72–78PubMedCrossRef Dugger BN, Boeve BF, Murray ME, Parisi JE, Fujishiro H, Dickson DW, Ferman TJ (2012a) Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies. Mov Disord 27:72–78PubMedCrossRef
go back to reference Dugger BN, Murray ME, Boeve BF, Parisi JE, Benarroch EE, Ferman TJ, Dickson DW (2012b) Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder. Neuropathol Appl Neurobiol 38:142–152PubMedPubMedCentralCrossRef Dugger BN, Murray ME, Boeve BF, Parisi JE, Benarroch EE, Ferman TJ, Dickson DW (2012b) Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder. Neuropathol Appl Neurobiol 38:142–152PubMedPubMedCentralCrossRef
go back to reference Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707PubMedCrossRef Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707PubMedCrossRef
go back to reference Evans AH, Okai D, Weintraub D, Lim SY, O’Sullivan SS, Voon V, Krack P, Sampaio C, Post B, Leentjens AFG, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A (2019) Scales to assess impulsive and compulsive behaviors in Parkinson’s disease: Critique and recommendations. Mov Disord 34:791–798PubMedCrossRef Evans AH, Okai D, Weintraub D, Lim SY, O’Sullivan SS, Voon V, Krack P, Sampaio C, Post B, Leentjens AFG, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A (2019) Scales to assess impulsive and compulsive behaviors in Parkinson’s disease: Critique and recommendations. Mov Disord 34:791–798PubMedCrossRef
go back to reference Fallon SJ, Plant O, Tabi YA, Manohar SG, Husain M (2023) Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias. Brain Commun 5:fcad207PubMedPubMedCentralCrossRef Fallon SJ, Plant O, Tabi YA, Manohar SG, Husain M (2023) Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias. Brain Commun 5:fcad207PubMedPubMedCentralCrossRef
go back to reference Ferman TJ, Boeve BF, Smith GE, Silber MH, Lucas JA, Graff-Radford NR, Dickson DW, Parisi JE, Petersen RC, Ivnik RJ (2002) Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations. J Int Neuropsychol Soc 8:907–914PubMedCrossRef Ferman TJ, Boeve BF, Smith GE, Silber MH, Lucas JA, Graff-Radford NR, Dickson DW, Parisi JE, Petersen RC, Ivnik RJ (2002) Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations. J Int Neuropsychol Soc 8:907–914PubMedCrossRef
go back to reference Ferreira D, Przybelski SA, Lesnick TG, Lemstra AW, Londos E, Blanc F, Nedelska Z, Schwarz CG, Graff-Radford J, Senjem ML, Fields JA, Knopman DS, Savica R, Ferman TJ, Graff-Radford NR, Lowe VJ, Jack CR Jr., Petersen RC, Mollenhauer B, Garcia-Ptacek S, Abdelnour C, Hort J, Bonanni L, Oppedal K, Kramberger MG, Boeve BF, Aarsland D, Westman E, Kantarci K (2020) beta-amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies. Neurology 95:e3257–e3268PubMedPubMedCentralCrossRef Ferreira D, Przybelski SA, Lesnick TG, Lemstra AW, Londos E, Blanc F, Nedelska Z, Schwarz CG, Graff-Radford J, Senjem ML, Fields JA, Knopman DS, Savica R, Ferman TJ, Graff-Radford NR, Lowe VJ, Jack CR Jr., Petersen RC, Mollenhauer B, Garcia-Ptacek S, Abdelnour C, Hort J, Bonanni L, Oppedal K, Kramberger MG, Boeve BF, Aarsland D, Westman E, Kantarci K (2020) beta-amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies. Neurology 95:e3257–e3268PubMedPubMedCentralCrossRef
go back to reference Figiel G, Sadowsky C (2008) A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders. Curr Med Res Opin 24:157–166PubMedCrossRef Figiel G, Sadowsky C (2008) A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders. Curr Med Res Opin 24:157–166PubMedCrossRef
go back to reference Firbank M, Kobeleva X, Cherry G, Killen A, Gallagher P, Burn DJ, Thomas AJ, O’Brien JT, Taylor JP (2016) Neural correlates of attention-executive dysfunction in Lewy body dementia and Alzheimer’s disease. Hum Brain Mapp 37:1254–1270PubMedCrossRef Firbank M, Kobeleva X, Cherry G, Killen A, Gallagher P, Burn DJ, Thomas AJ, O’Brien JT, Taylor JP (2016) Neural correlates of attention-executive dysfunction in Lewy body dementia and Alzheimer’s disease. Hum Brain Mapp 37:1254–1270PubMedCrossRef
go back to reference Fujishiro H, Iseki E, Murayama N, Yamamoto R, Higashi S, Kasanuki K, Suzuki M, Arai H, Sato K (2010) Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with. Lewy Bodies? Psychogeriatr 10:144–152CrossRef Fujishiro H, Iseki E, Murayama N, Yamamoto R, Higashi S, Kasanuki K, Suzuki M, Arai H, Sato K (2010) Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with. Lewy Bodies? Psychogeriatr 10:144–152CrossRef
go back to reference Geng C, Tan L, Chen C (2024) Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias. Brain Res 1833:148881PubMedCrossRef Geng C, Tan L, Chen C (2024) Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias. Brain Res 1833:148881PubMedCrossRef
go back to reference Génier Marchand D, Postuma RB, Escudier F, De Roy J, Pelletier A, Montplaisir J, Gagnon JF (2018) How does dementia with Lewy bodies start? Prodromal cognitive changes in REM sleep behavior disorder. Ann Neurol 83:1016–1026PubMedCrossRef Génier Marchand D, Postuma RB, Escudier F, De Roy J, Pelletier A, Montplaisir J, Gagnon JF (2018) How does dementia with Lewy bodies start? Prodromal cognitive changes in REM sleep behavior disorder. Ann Neurol 83:1016–1026PubMedCrossRef
go back to reference Genro JP, Kieling C, Rohde LA, Hutz MH (2010) Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses. Expert Rev Neurother 10:587–601PubMedCrossRef Genro JP, Kieling C, Rohde LA, Hutz MH (2010) Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses. Expert Rev Neurother 10:587–601PubMedCrossRef
go back to reference Goetz CG, Emre M, Dubois B (2008) Parkinson’s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81–92PubMed Goetz CG, Emre M, Dubois B (2008) Parkinson’s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81–92PubMed
go back to reference Golimstok A, Rojas JI, Romano M, Zurru MC, Doctorovich D, Cristiano E (2011) Previous adult attention-deficit and hyperactivity disorder symptoms and risk of dementia with Lewy bodies: a case-control study. Eur J Neurol 18:78–84PubMedCrossRef Golimstok A, Rojas JI, Romano M, Zurru MC, Doctorovich D, Cristiano E (2011) Previous adult attention-deficit and hyperactivity disorder symptoms and risk of dementia with Lewy bodies: a case-control study. Eur J Neurol 18:78–84PubMedCrossRef
go back to reference Golimstok Á, Basalo MJG, Majul M, Berrios W, Rugiero M, Fernández MC, Eichel R (2024) Adult attention deficit-hyperactivity disorder is associated with Lewy body disease and cognitive impairment: a prospective cohort study with 15-year follow-up. Am J Geriatr Psychiatry 32:1063–1077. https://doi.org/10.1016/j.jagp.2024.1004.1005 Golimstok Á, Basalo MJG, Majul M, Berrios W, Rugiero M, Fernández MC, Eichel R (2024) Adult attention deficit-hyperactivity disorder is associated with Lewy body disease and cognitive impairment: a prospective cohort study with 15-year follow-up. Am J Geriatr Psychiatry 32:1063–1077. https://​doi.​org/​10.​1016/​j.​jagp.​2024.​1004.​1005
go back to reference Hynninen MJ, Breitve MH, Rongve A, Aarsland D, Nordhus IH (2012) The frequency and correlates of anxiety in patients with first-time diagnosed mild dementia. Int Psychogeriatr 24:1771–1778PubMedCrossRef Hynninen MJ, Breitve MH, Rongve A, Aarsland D, Nordhus IH (2012) The frequency and correlates of anxiety in patients with first-time diagnosed mild dementia. Int Psychogeriatr 24:1771–1778PubMedCrossRef
go back to reference Iaccarino L, Marelli S, Iannaccone S, Magnani G, Ferini-Strambi L, Perani D (2016) Severe brain metabolic decreases associated with REM sleep behavior disorder in dementia with Lewy bodies. J Alzheimers Dis 52:989–997PubMedCrossRef Iaccarino L, Marelli S, Iannaccone S, Magnani G, Ferini-Strambi L, Perani D (2016) Severe brain metabolic decreases associated with REM sleep behavior disorder in dementia with Lewy bodies. J Alzheimers Dis 52:989–997PubMedCrossRef
go back to reference Ikeda M, Mori E, Matsuo K, Nakagawa M, Kosaka K (2015) Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial. Alzheimers Res Ther 7:4PubMedPubMedCentralCrossRef Ikeda M, Mori E, Matsuo K, Nakagawa M, Kosaka K (2015) Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial. Alzheimers Res Ther 7:4PubMedPubMedCentralCrossRef
go back to reference Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, Sanchez-Valle R, Vilaseca I, Lomeña F, Vilas D, Lladó A, Gaig C, Santamaria J (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–453PubMedCrossRef Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, Sanchez-Valle R, Vilaseca I, Lomeña F, Vilas D, Lladó A, Gaig C, Santamaria J (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–453PubMedCrossRef
go back to reference Jaidi Y, Nonnonhou V, Kanagaratnam L, Bertholon LA, Badr S, Noël V, Novella JL, Mahmoudi R (2018) Reduction of the anticholinergic burden makes it possible to decrease behavioral and psychological symptoms of dementia. Am J Geriatr Psychiatry 26:280–288PubMedCrossRef Jaidi Y, Nonnonhou V, Kanagaratnam L, Bertholon LA, Badr S, Noël V, Novella JL, Mahmoudi R (2018) Reduction of the anticholinergic burden makes it possible to decrease behavioral and psychological symptoms of dementia. Am J Geriatr Psychiatry 26:280–288PubMedCrossRef
go back to reference Jellinger KA (2023) Depression in dementia with Lewy bodies: a critical update. J Neural Transm (Vienna) 130:1207–1218PubMedCrossRef Jellinger KA (2023) Depression in dementia with Lewy bodies: a critical update. J Neural Transm (Vienna) 130:1207–1218PubMedCrossRef
go back to reference Joza S, Hu MT, Jung KY, Kunz D, Stefani A, Dušek P, Terzaghi M, Arnaldi D, Videnovic A, Schiess MC, Hermann W, Lee JY, Ferini-Strambi L, Lewis SJG, Leclair-Visonneau L, Oertel WH, Antelmi E, Sixel-Döring F, Cochen De Cock V, Liguori C, Liu J, Provini F, Puligheddu M, Nicoletti A, Bassetti CLA, Bušková J, Dauvilliers Y, Ferri R, Montplaisir JY, Lawton M, Kim HJ, Bes F, Högl B, Šonka K, Fiamingo G, Mattioli P, Lavadia ML, Suescun J, Woo KA, Marelli S, Martens KE, Janzen A, Plazzi G, Mollenhauer B, Fernandes M, Li Y, Cortelli P, Figorilli M, Cicero CE, Schaefer C, Guiraud L, Lanza G, Gagnon JF, Sunwoo JS, Ibrahim A, Girtler N, Trenkwalder C, Baldelli L, Pelletier A, Postuma RB (2023) Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study. Brain 146:3258–3272PubMedCrossRef Joza S, Hu MT, Jung KY, Kunz D, Stefani A, Dušek P, Terzaghi M, Arnaldi D, Videnovic A, Schiess MC, Hermann W, Lee JY, Ferini-Strambi L, Lewis SJG, Leclair-Visonneau L, Oertel WH, Antelmi E, Sixel-Döring F, Cochen De Cock V, Liguori C, Liu J, Provini F, Puligheddu M, Nicoletti A, Bassetti CLA, Bušková J, Dauvilliers Y, Ferri R, Montplaisir JY, Lawton M, Kim HJ, Bes F, Högl B, Šonka K, Fiamingo G, Mattioli P, Lavadia ML, Suescun J, Woo KA, Marelli S, Martens KE, Janzen A, Plazzi G, Mollenhauer B, Fernandes M, Li Y, Cortelli P, Figorilli M, Cicero CE, Schaefer C, Guiraud L, Lanza G, Gagnon JF, Sunwoo JS, Ibrahim A, Girtler N, Trenkwalder C, Baldelli L, Pelletier A, Postuma RB (2023) Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study. Brain 146:3258–3272PubMedCrossRef
go back to reference Joza S, Hu MT, Jung KY, Kunz D, Arnaldi D, Lee JY, Ferini-Strambi L, Antelmi E, Sixel-Döring F, De Cock VC, Montplaisir JY, Welch J, Kim HJ, Bes F, Mattioli P, Woo KA, Marelli S, Plazzi G, Mollenhauer B, Pelletier A, Razzaque J, Sunwoo JS, Girtler N, Trenkwalder C, Gagnon JF, Postuma RB (2024) Prodromal dementia with Lewy bodies in REM sleep behavior disorder: a multicenter study. Alzheimers Dement 20:91–102PubMedCrossRef Joza S, Hu MT, Jung KY, Kunz D, Arnaldi D, Lee JY, Ferini-Strambi L, Antelmi E, Sixel-Döring F, De Cock VC, Montplaisir JY, Welch J, Kim HJ, Bes F, Mattioli P, Woo KA, Marelli S, Plazzi G, Mollenhauer B, Pelletier A, Razzaque J, Sunwoo JS, Girtler N, Trenkwalder C, Gagnon JF, Postuma RB (2024) Prodromal dementia with Lewy bodies in REM sleep behavior disorder: a multicenter study. Alzheimers Dement 20:91–102PubMedCrossRef
go back to reference Jurek L, Herrmann M, Bonze M, Brunet S, Padovan C, Dorey JM (2018) Behavioral and psychological symptoms in Lewy body disease: a review. Geriatr Psychol Neuropsychiatr Vieil 16:87–95PubMed Jurek L, Herrmann M, Bonze M, Brunet S, Padovan C, Dorey JM (2018) Behavioral and psychological symptoms in Lewy body disease: a review. Geriatr Psychol Neuropsychiatr Vieil 16:87–95PubMed
go back to reference Kantarci K, Ferman TJ, Boeve BF, Weigand SD, Przybelski S, Vemuri P, Murray ME, Senjem ML, Smith GE, Knopman DS, Petersen RC, Jack CR Jr., Parisi JE, Dickson DW (2012) Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology 79:553–560PubMedPubMedCentralCrossRef Kantarci K, Ferman TJ, Boeve BF, Weigand SD, Przybelski S, Vemuri P, Murray ME, Senjem ML, Smith GE, Knopman DS, Petersen RC, Jack CR Jr., Parisi JE, Dickson DW (2012) Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology 79:553–560PubMedPubMedCentralCrossRef
go back to reference Kazui H, Yoshiyama K, Kanemoto H, Suzuki Y, Sato S, Hashimoto M, Ikeda M, Tanaka H, Hatada Y, Matsushita M, Nishio Y, Mori E, Tanimukai S, Komori K, Yoshida T, Shimizu H, Matsumoto T, Mori T, Kashibayashi T, Yokoyama K, Shimomura T, Kabeshita Y, Adachi H, Tanaka T (2016) Differences of behavioral and psychological symptoms of dementia in disease severity in four major dementias. PLoS ONE 11:e0161092PubMedPubMedCentralCrossRef Kazui H, Yoshiyama K, Kanemoto H, Suzuki Y, Sato S, Hashimoto M, Ikeda M, Tanaka H, Hatada Y, Matsushita M, Nishio Y, Mori E, Tanimukai S, Komori K, Yoshida T, Shimizu H, Matsumoto T, Mori T, Kashibayashi T, Yokoyama K, Shimomura T, Kabeshita Y, Adachi H, Tanaka T (2016) Differences of behavioral and psychological symptoms of dementia in disease severity in four major dementias. PLoS ONE 11:e0161092PubMedPubMedCentralCrossRef
go back to reference Kimura T, Hayashida H, Murata M, Takamatsu J (2011) Effect of ferulic acid and Angelica archangelica extract on behavioral and psychological symptoms of dementia in frontotemporal lobar degeneration and dementia with Lewy bodies. Geriatr Gerontol Int 11:309–314PubMedCrossRef Kimura T, Hayashida H, Murata M, Takamatsu J (2011) Effect of ferulic acid and Angelica archangelica extract on behavioral and psychological symptoms of dementia in frontotemporal lobar degeneration and dementia with Lewy bodies. Geriatr Gerontol Int 11:309–314PubMedCrossRef
go back to reference Kitamura T, Tochimoto S, Kitamura M, Madachi S, Hino S (2015) Outcomes of inpatient treatment for behavioral and psychological symptoms of dementia in Alzheimer’s disease versus dementia with Lewy bodies. Prim Care Companion CNS Disord 17 Kitamura T, Tochimoto S, Kitamura M, Madachi S, Hino S (2015) Outcomes of inpatient treatment for behavioral and psychological symptoms of dementia in Alzheimer’s disease versus dementia with Lewy bodies. Prim Care Companion CNS Disord 17
go back to reference Koo DL, Lee JY, Nam H (2018) Difference in severity of sleep apnea in patients with rapid eye movement sleep behavior disorder with or without parkinsonism. Sleep Med 49:99–104PubMedCrossRef Koo DL, Lee JY, Nam H (2018) Difference in severity of sleep apnea in patients with rapid eye movement sleep behavior disorder with or without parkinsonism. Sleep Med 49:99–104PubMedCrossRef
go back to reference Lai TT, Gericke B, Feja M, Conoscenti M, Zelikowsky M, Richter F (2023) Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies. NPJ Parkinsons Dis 9:97PubMedPubMedCentralCrossRef Lai TT, Gericke B, Feja M, Conoscenti M, Zelikowsky M, Richter F (2023) Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies. NPJ Parkinsons Dis 9:97PubMedPubMedCentralCrossRef
go back to reference Larsson V, Aarsland D, Ballard C, Minthon L, Londos E (2010) The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson’s disease dementia. Int J Geriatr Psychiatry 25:1030–1038PubMedCrossRef Larsson V, Aarsland D, Ballard C, Minthon L, Londos E (2010) The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson’s disease dementia. Int J Geriatr Psychiatry 25:1030–1038PubMedCrossRef
go back to reference Lee CY, Cheng SJ, Lin HC, Liao YL, Chen PH (2018) Quality of life in patients with dementia with Lewy bodies. Behav Neurol 2018:8320901 Lee CY, Cheng SJ, Lin HC, Liao YL, Chen PH (2018) Quality of life in patients with dementia with Lewy bodies. Behav Neurol 2018:8320901
go back to reference Leverenz JB, Miller MA, Dobie DJ, Peskind ER, Raskind MA (2001) Increased alpha 2-adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies. Neurobiol Aging 22:555–561PubMedCrossRef Leverenz JB, Miller MA, Dobie DJ, Peskind ER, Raskind MA (2001) Increased alpha 2-adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies. Neurobiol Aging 22:555–561PubMedCrossRef
go back to reference Li L, Wang JT, Zhang ZX, Cui RX, Yuan J (2011) [Clinical features and treatment of dementia with Lewy bodies]. Zhonghua Yi Xue Za Zhi 91:1617–1620PubMed Li L, Wang JT, Zhang ZX, Cui RX, Yuan J (2011) [Clinical features and treatment of dementia with Lewy bodies]. Zhonghua Yi Xue Za Zhi 91:1617–1620PubMed
go back to reference Liu J, Cooper CA, Weintraub D, Dahodwala N (2019) Pharmacological treatment of apathy in Lewy body disorders: a systematic review. Parkinsonism Relat Disord 60:14–24PubMedCrossRef Liu J, Cooper CA, Weintraub D, Dahodwala N (2019) Pharmacological treatment of apathy in Lewy body disorders: a systematic review. Parkinsonism Relat Disord 60:14–24PubMedCrossRef
go back to reference Liu L, Shi Z, Gan J, Liu S, Wen C, Yang Y, Yang F, Ji Y (2024) Characterization of de novo dementia with Lewy Body with different duration of rapid eye movement sleep behavior disorder. Sleep Med 114:101–108PubMedCrossRef Liu L, Shi Z, Gan J, Liu S, Wen C, Yang Y, Yang F, Ji Y (2024) Characterization of de novo dementia with Lewy Body with different duration of rapid eye movement sleep behavior disorder. Sleep Med 114:101–108PubMedCrossRef
go back to reference Manabe Y, Ino T, Yamanaka K, Kosaka K (2016) Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies. Psychogeriatrics 16:202–208PubMedCrossRef Manabe Y, Ino T, Yamanaka K, Kosaka K (2016) Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies. Psychogeriatrics 16:202–208PubMedCrossRef
go back to reference Marra C, Quaranta D, Profice P, Pilato F, Capone F, Iodice F, Di Lazzaro V, Gainotti G (2012) Central cholinergic dysfunction measured in vivo correlates with different behavioral disorders in Alzheimer’s disease and dementia with Lewy body. Brain Stimul 5:533–538PubMedCrossRef Marra C, Quaranta D, Profice P, Pilato F, Capone F, Iodice F, Di Lazzaro V, Gainotti G (2012) Central cholinergic dysfunction measured in vivo correlates with different behavioral disorders in Alzheimer’s disease and dementia with Lewy body. Brain Stimul 5:533–538PubMedCrossRef
go back to reference Mavroudis I, Petridis F, Kazis D (2019) Cerebrospinal fluid, imaging, and physiological biomarkers in dementia with Lewy bodies. Am J Alzheimers Dis Other Demen 34:421–432PubMedPubMedCentralCrossRef Mavroudis I, Petridis F, Kazis D (2019) Cerebrospinal fluid, imaging, and physiological biomarkers in dementia with Lewy bodies. Am J Alzheimers Dis Other Demen 34:421–432PubMedPubMedCentralCrossRef
go back to reference McKeith IG, Fairbairn AF, Perry RH, Thompson P (1994) The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry 165:324–332PubMedCrossRef McKeith IG, Fairbairn AF, Perry RH, Thompson P (1994) The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry 165:324–332PubMedCrossRef
go back to reference McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88–100PubMedPubMedCentralCrossRef McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88–100PubMedPubMedCentralCrossRef
go back to reference McWilliam O, Gramkow MH, Blaabjerg M, Clemmensen FK, Hasselbalch SG, Frederiksen KS (2024) Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review. J Neurol 271:1707–1716PubMedCrossRef McWilliam O, Gramkow MH, Blaabjerg M, Clemmensen FK, Hasselbalch SG, Frederiksen KS (2024) Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review. J Neurol 271:1707–1716PubMedCrossRef
go back to reference Miyamoto T, Miyamoto M (2018) Phenoconversion from idiopathic rapid eye movement sleep behavior disorder to Lewy body disease. Mov Disord Clin Pract 5:506–511PubMedPubMedCentralCrossRef Miyamoto T, Miyamoto M (2018) Phenoconversion from idiopathic rapid eye movement sleep behavior disorder to Lewy body disease. Mov Disord Clin Pract 5:506–511PubMedPubMedCentralCrossRef
go back to reference Miyamoto M, Miyamoto T (2022) Montreal cognitive assessment predicts the short-term risk of Lewy body disease in isolated REM sleep behavior disorder with reduced MIBG scintigraphy. Mov Disord Clin Pract 10:32–41PubMedPubMedCentralCrossRef Miyamoto M, Miyamoto T (2022) Montreal cognitive assessment predicts the short-term risk of Lewy body disease in isolated REM sleep behavior disorder with reduced MIBG scintigraphy. Mov Disord Clin Pract 10:32–41PubMedPubMedCentralCrossRef
go back to reference Miyamoto T, Miyamoto M, Numahata K, Onoue H, Akaiwa Y, Sairenchi T (2020) Reduced dopamine transporter binding predicts early transition to Lewy body disease in Japanese patients with idiopathic rapid eye movement sleep behavior disorder. J Neurol Sci 414:116821PubMedCrossRef Miyamoto T, Miyamoto M, Numahata K, Onoue H, Akaiwa Y, Sairenchi T (2020) Reduced dopamine transporter binding predicts early transition to Lewy body disease in Japanese patients with idiopathic rapid eye movement sleep behavior disorder. J Neurol Sci 414:116821PubMedCrossRef
go back to reference Mori E, Ikeda M, Kosaka K (2012) Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol 72:41–52PubMedCrossRef Mori E, Ikeda M, Kosaka K (2012) Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol 72:41–52PubMedCrossRef
go back to reference Mori E, Ikeda M, Nagai R, Matsuo K, Nakagawa M, Kosaka K (2015) Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial. Alzheimers Res Ther 7:5PubMedPubMedCentralCrossRef Mori E, Ikeda M, Nagai R, Matsuo K, Nakagawa M, Kosaka K (2015) Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial. Alzheimers Res Ther 7:5PubMedPubMedCentralCrossRef
go back to reference Morris LA, Harrison SJ, Melzer TR, Dalrymple-Alford JC, Anderson TJ, MacAskill MR, Le Heron CJ (2023) Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease. Brain 146:2739–2752PubMedPubMedCentralCrossRef Morris LA, Harrison SJ, Melzer TR, Dalrymple-Alford JC, Anderson TJ, MacAskill MR, Le Heron CJ (2023) Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease. Brain 146:2739–2752PubMedPubMedCentralCrossRef
go back to reference Muller C, Merignac J, Moog C, Schorr B, Javelot H, Blanc F (2023) [Pimavanserin and trazodone combination in behavioral disorders in severe dementia with Lewy bodies]. Geriatr Psychol Neuropsychiatr Vieil 21:116–127PubMed Muller C, Merignac J, Moog C, Schorr B, Javelot H, Blanc F (2023) [Pimavanserin and trazodone combination in behavioral disorders in severe dementia with Lewy bodies]. Geriatr Psychol Neuropsychiatr Vieil 21:116–127PubMed
go back to reference Murray ME, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Liesinger AM, Senjem ML, Gunter JL, Preboske GM, Lowe VJ, Vemuri P, Dugger BN, Knopman DS, Smith GE, Parisi JE, Silber MH, Graff-Radford NR, Petersen RC, Jack CR Jr., Dickson DW, Kantarci K (2013) MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies. Neurology 81:1681–1689PubMedPubMedCentralCrossRef Murray ME, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Liesinger AM, Senjem ML, Gunter JL, Preboske GM, Lowe VJ, Vemuri P, Dugger BN, Knopman DS, Smith GE, Parisi JE, Silber MH, Graff-Radford NR, Petersen RC, Jack CR Jr., Dickson DW, Kantarci K (2013) MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies. Neurology 81:1681–1689PubMedPubMedCentralCrossRef
go back to reference Nicastro N, Mak E, Surendranathan A, Rittman T, Rowe JB, O’Brien JT (2021) Altered structural connectivity networks in dementia with Lewy bodies. Brain Imaging Behav 15:2445–2453PubMedPubMedCentralCrossRef Nicastro N, Mak E, Surendranathan A, Rittman T, Rowe JB, O’Brien JT (2021) Altered structural connectivity networks in dementia with Lewy bodies. Brain Imaging Behav 15:2445–2453PubMedPubMedCentralCrossRef
go back to reference Onor ML, Saina M, Aguglia E (2006) Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia. Am J Alzheimers Dis Other Demen 21:448–453PubMedCrossRef Onor ML, Saina M, Aguglia E (2006) Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia. Am J Alzheimers Dis Other Demen 21:448–453PubMedCrossRef
go back to reference Ota K, Fujishiro H, Kasanuki K, Kondo D, Chiba Y, Murayama N, Arai H, Sato K, Iseki E (2016) Prediction of later clinical course by a specific glucose metabolic pattern in non-demented patients with probable REM sleep behavior disorder admitted to a memory clinic: a case study. Psychiatry Res Neuroimaging 248:151–158PubMedCrossRef Ota K, Fujishiro H, Kasanuki K, Kondo D, Chiba Y, Murayama N, Arai H, Sato K, Iseki E (2016) Prediction of later clinical course by a specific glucose metabolic pattern in non-demented patients with probable REM sleep behavior disorder admitted to a memory clinic: a case study. Psychiatry Res Neuroimaging 248:151–158PubMedCrossRef
go back to reference Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5PubMedPubMedCentralCrossRef Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5PubMedPubMedCentralCrossRef
go back to reference Palermo G, Belli E, Tommasini L, Morganti R, Frosini D, Nicoletti V, Tognoni G, Siciliano G, Bonuccelli U, Baldacci F, Ceravolo R (2021) Dissecting the interplay between time of dementia and cognitive profiles in Lewy body dementias. J Alzheimers Dis 84:757–766PubMedCrossRef Palermo G, Belli E, Tommasini L, Morganti R, Frosini D, Nicoletti V, Tognoni G, Siciliano G, Bonuccelli U, Baldacci F, Ceravolo R (2021) Dissecting the interplay between time of dementia and cognitive profiles in Lewy body dementias. J Alzheimers Dis 84:757–766PubMedCrossRef
go back to reference Paniak I, Lewis SJG, Ehgoetz Martens KA (2021) Measuring anxiety in Lewy body disease - which scale to choose? Clin Park Relat Disord 5:100110PubMedPubMedCentral Paniak I, Lewis SJG, Ehgoetz Martens KA (2021) Measuring anxiety in Lewy body disease - which scale to choose? Clin Park Relat Disord 5:100110PubMedPubMedCentral
go back to reference Paumier KL, Sukoff Rizzo SJ, Berger Z, Chen Y, Gonzales C, Kaftan E, Li L, Lotarski S, Monaghan M, Shen W, Stolyar P, Vasilyev D, Zaleska M, Hirst WD, Dunlop J (2013) Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson’s disease. PLoS ONE 8:e70274PubMedPubMedCentralCrossRef Paumier KL, Sukoff Rizzo SJ, Berger Z, Chen Y, Gonzales C, Kaftan E, Li L, Lotarski S, Monaghan M, Shen W, Stolyar P, Vasilyev D, Zaleska M, Hirst WD, Dunlop J (2013) Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson’s disease. PLoS ONE 8:e70274PubMedPubMedCentralCrossRef
go back to reference Peavy GM, Salmon DP, Edland SD, Tam S, Hansen LA, Masliah E, Galasko D, Hamilton JM (2013) Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with Lewy bodies and pure Alzheimer disease. Am J Geriatr Psychiatry 21:509–519PubMedPubMedCentralCrossRef Peavy GM, Salmon DP, Edland SD, Tam S, Hansen LA, Masliah E, Galasko D, Hamilton JM (2013) Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with Lewy bodies and pure Alzheimer disease. Am J Geriatr Psychiatry 21:509–519PubMedPubMedCentralCrossRef
go back to reference Pillai JA, Bena J, Rothenberg K, Boron B, Leverenz JB (2022) Association of variation in behavioral symptoms with initial cognitive phenotype in adults with dementia confirmed by neuropathology. JAMA Netw Open 5:e220729PubMedPubMedCentralCrossRef Pillai JA, Bena J, Rothenberg K, Boron B, Leverenz JB (2022) Association of variation in behavioral symptoms with initial cognitive phenotype in adults with dementia confirmed by neuropathology. JAMA Netw Open 5:e220729PubMedPubMedCentralCrossRef
go back to reference Prakash R, Pathak A, Munda S, Bagati D (2009) Quetiapine effective in treatment of inappropriate sexual behavior of Lewy body disease with predominant frontal lobe signs. Am J Alzheimers Dis Other Demen 24:136–140PubMedPubMedCentralCrossRef Prakash R, Pathak A, Munda S, Bagati D (2009) Quetiapine effective in treatment of inappropriate sexual behavior of Lewy body disease with predominant frontal lobe signs. Am J Alzheimers Dis Other Demen 24:136–140PubMedPubMedCentralCrossRef
go back to reference Prentice JL, Schaeffer MJ, Wall AK, Callahan BL (2021) A systematic review and comparison of neurocognitive features of late-life attention-deficit/hyperactivity disorder and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 34:466–481PubMedCrossRef Prentice JL, Schaeffer MJ, Wall AK, Callahan BL (2021) A systematic review and comparison of neurocognitive features of late-life attention-deficit/hyperactivity disorder and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 34:466–481PubMedCrossRef
go back to reference Puigròs M, Calderon A, Martín-Ruiz D, Serradell M, Fernández M, Muñoz-Lopetegi A, Mayà G, Santamaria J, Gaig C, Colell A, Tolosa E, Iranzo A, Trullas R (2024) Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorder. EBioMedicine 102:105065PubMedPubMedCentralCrossRef Puigròs M, Calderon A, Martín-Ruiz D, Serradell M, Fernández M, Muñoz-Lopetegi A, Mayà G, Santamaria J, Gaig C, Colell A, Tolosa E, Iranzo A, Trullas R (2024) Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorder. EBioMedicine 102:105065PubMedPubMedCentralCrossRef
go back to reference Radakovic R, Gray D, Dudley K, Mioshi E, Dick D, Melchiorre G, Gordon H, Newton J, Colville S, Pal S, Chandran S, Abrahams S (2020) Reliability and validity of the brief dimensional apathy scale. Arch Clin Neuropsychol 35:539–544PubMedCrossRef Radakovic R, Gray D, Dudley K, Mioshi E, Dick D, Melchiorre G, Gordon H, Newton J, Colville S, Pal S, Chandran S, Abrahams S (2020) Reliability and validity of the brief dimensional apathy scale. Arch Clin Neuropsychol 35:539–544PubMedCrossRef
go back to reference Ramm RM, Lerner ZI, Levy-Meeks GS, Burke RV, Raven MC, Song A, Glass MH (2023) A case report of treatment-resistant agitation in dementia with Lewy bodies: medical marijuana as an alternative to antipsychotics. J Palliat Med 26:737–740PubMedCrossRef Ramm RM, Lerner ZI, Levy-Meeks GS, Burke RV, Raven MC, Song A, Glass MH (2023) A case report of treatment-resistant agitation in dementia with Lewy bodies: medical marijuana as an alternative to antipsychotics. J Palliat Med 26:737–740PubMedCrossRef
go back to reference Rowan E, McKeith IG, Saxby BK, O’Brien JT, Burn D, Mosimann U, Newby J, Daniel S, Sanders J, Wesnes K (2007) Effects of Donepezil on central processing speed and attentional measures in Parkinson’s disease with dementia and dementia with Lewy bodies. Dement Geriatr Cogn Disord 23:161–167PubMedCrossRef Rowan E, McKeith IG, Saxby BK, O’Brien JT, Burn D, Mosimann U, Newby J, Daniel S, Sanders J, Wesnes K (2007) Effects of Donepezil on central processing speed and attentional measures in Parkinson’s disease with dementia and dementia with Lewy bodies. Dement Geriatr Cogn Disord 23:161–167PubMedCrossRef
go back to reference Samudra N, Fischer DL, Lenio S, Lario Lago A, Ljubenkov PA, Rojas JC, Seeley WW, Spina S, Staffaroni AM, Tablante J, Wekselman F, Lamoureux J, Concha-Marambio L, Grinberg LT, Boxer AL, VandeVrede L (2024) Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort. Alzheimers Dement 20:3334–3341PubMedPubMedCentralCrossRef Samudra N, Fischer DL, Lenio S, Lario Lago A, Ljubenkov PA, Rojas JC, Seeley WW, Spina S, Staffaroni AM, Tablante J, Wekselman F, Lamoureux J, Concha-Marambio L, Grinberg LT, Boxer AL, VandeVrede L (2024) Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort. Alzheimers Dement 20:3334–3341PubMedPubMedCentralCrossRef
go back to reference Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, Campdelacreu J, Gascon J, Falcon C, Calopa M, Jauma S, Juncadella M, Junque C (2009) Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson’s disease with dementia. Mov Disord 24:1740–1746PubMedCrossRef Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, Campdelacreu J, Gascon J, Falcon C, Calopa M, Jauma S, Juncadella M, Junque C (2009) Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson’s disease with dementia. Mov Disord 24:1740–1746PubMedCrossRef
go back to reference Schreinzer D, Ballaban T, Brannath W, Lang T, Hilger E, Fasching P, Fischer P (2005) Components of behavioral pathology in dementia. Int J Geriatr Psychiatry 20:137–145PubMedCrossRef Schreinzer D, Ballaban T, Brannath W, Lang T, Hilger E, Fasching P, Fischer P (2005) Components of behavioral pathology in dementia. Int J Geriatr Psychiatry 20:137–145PubMedCrossRef
go back to reference Schumacher J, Cromarty R, Gallagher P, Firbank MJ, Thomas AJ, Kaiser M, Blamire AM, O’Brien JT, Peraza LR, Taylor JP (2019) Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer’s disease: an ex-gaussian analysis. J Neurol 266:1716–1726PubMedPubMedCentralCrossRef Schumacher J, Cromarty R, Gallagher P, Firbank MJ, Thomas AJ, Kaiser M, Blamire AM, O’Brien JT, Peraza LR, Taylor JP (2019) Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer’s disease: an ex-gaussian analysis. J Neurol 266:1716–1726PubMedPubMedCentralCrossRef
go back to reference Schwertner E, Pereira JB, Xu H, Secnik J, Winblad B, Eriksdotter M, Nägga K, Religa D (2022) Behavioral and psychological symptoms of dementia in different dementia disorders: a large-scale study of 10,000 individuals. J Alzheimers Dis 87:1307–1318PubMedPubMedCentralCrossRef Schwertner E, Pereira JB, Xu H, Secnik J, Winblad B, Eriksdotter M, Nägga K, Religa D (2022) Behavioral and psychological symptoms of dementia in different dementia disorders: a large-scale study of 10,000 individuals. J Alzheimers Dis 87:1307–1318PubMedPubMedCentralCrossRef
go back to reference Segers K, Baxevani E, Benoit F, Meyts JM, Surquin M (2020a) Pregabalin as a treatment for anxiety in patients with dementia with Lewy bodies: a case series. J Clin Psychopharmacol 40:297–299PubMedCrossRef Segers K, Baxevani E, Benoit F, Meyts JM, Surquin M (2020a) Pregabalin as a treatment for anxiety in patients with dementia with Lewy bodies: a case series. J Clin Psychopharmacol 40:297–299PubMedCrossRef
go back to reference Segers K, Benoit F, Meyts JM, Surquin M (2020b) Anxiety symptoms are quantitatively and qualitatively different in dementia with Lewy bodies than in Alzheimer’s disease in the years preceding clinical diagnosis. Psychogeriatrics 20:242–246PubMedCrossRef Segers K, Benoit F, Meyts JM, Surquin M (2020b) Anxiety symptoms are quantitatively and qualitatively different in dementia with Lewy bodies than in Alzheimer’s disease in the years preceding clinical diagnosis. Psychogeriatrics 20:242–246PubMedCrossRef
go back to reference Sekiguchi H, Moriwaki M, Iritani S, Habuchi C, Torii Y, Umeda K, Fujishiro H, Yoshida M, Fujita K (2017) An autopsy case of dementia with Lewy bodies clinically diagnosed to have a behavioral variant of frontotemporal dementia. Clin Neuropathol 36:23–30 Sekiguchi H, Moriwaki M, Iritani S, Habuchi C, Torii Y, Umeda K, Fujishiro H, Yoshida M, Fujita K (2017) An autopsy case of dementia with Lewy bodies clinically diagnosed to have a behavioral variant of frontotemporal dementia. Clin Neuropathol 36:23–30
go back to reference Shin JH, Kim H, Kim YK, Yoon EJ, Nam H, Jeon B, Lee JY (2023) Longitudinal evolution of cortical thickness signature reflecting Lewy body dementia in isolated REM sleep behavior disorder: a prospective cohort study. Transl Neurodegener 12:27PubMedPubMedCentralCrossRef Shin JH, Kim H, Kim YK, Yoon EJ, Nam H, Jeon B, Lee JY (2023) Longitudinal evolution of cortical thickness signature reflecting Lewy body dementia in isolated REM sleep behavior disorder: a prospective cohort study. Transl Neurodegener 12:27PubMedPubMedCentralCrossRef
go back to reference Siepel FJ, Dalen I, Grüner R, Booij J, Brønnick KS, Buter TC, Aarsland D (2016) Loss of dopamine transporter binding and clinical symptoms in dementia with Lewy bodies. Mov Disord 31:118–125PubMedCrossRef Siepel FJ, Dalen I, Grüner R, Booij J, Brønnick KS, Buter TC, Aarsland D (2016) Loss of dopamine transporter binding and clinical symptoms in dementia with Lewy bodies. Mov Disord 31:118–125PubMedCrossRef
go back to reference Sim J, Li H, Hameed S, Ting SKS (2022) Clinical manifestations of early-onset dementia with Lewy bodies compared with late-onset dementia with Lewy bodies and early-onset Alzheimer disease. JAMA Neurol 79:702–709PubMedCrossRef Sim J, Li H, Hameed S, Ting SKS (2022) Clinical manifestations of early-onset dementia with Lewy bodies compared with late-onset dementia with Lewy bodies and early-onset Alzheimer disease. JAMA Neurol 79:702–709PubMedCrossRef
go back to reference Simard M, van Reekum R, Cohen T (2000) A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 12:425–450PubMedCrossRef Simard M, van Reekum R, Cohen T (2000) A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 12:425–450PubMedCrossRef
go back to reference Skogseth R, Hortobágyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D (2017) Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology. J Alzheimers Dis 59:1139–1152PubMedCrossRef Skogseth R, Hortobágyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D (2017) Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology. J Alzheimers Dis 59:1139–1152PubMedCrossRef
go back to reference Somerville EN, Krohn L, Yu E, Rudakou U, Senkevich K, Ruskey JA, Asayesh F, Ahmad J, Spiegelman D, Dauvilliers Y, Arnulf I, Hu MTM, Montplaisir JY, Gagnon JF, Desautels A, Ibrahim A, Stefani A, Högl B, Gigli GL, Valente M, Janes F, Bernardini A, Dusek P, Sonka K, Kemlink D, Plazzi G, Antelmi E, Biscarini F, Mollenhauer B, Trenkwalder C, Sixel-Doring F, Figorilli M, Puligheddu M, De Cock VC, Oertel W, Janzen A, Ferini-Strambi L, Heibreder A, Monaca CC, Abril B, Dijkstra F, Viaene M, Boeve BF, Postuma RB, Rouleau GA, Gan-Or Z (2023) NPC1 variants are not associated with Parkinson’s disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts. Neurobiol Aging 127:94–98PubMedCrossRef Somerville EN, Krohn L, Yu E, Rudakou U, Senkevich K, Ruskey JA, Asayesh F, Ahmad J, Spiegelman D, Dauvilliers Y, Arnulf I, Hu MTM, Montplaisir JY, Gagnon JF, Desautels A, Ibrahim A, Stefani A, Högl B, Gigli GL, Valente M, Janes F, Bernardini A, Dusek P, Sonka K, Kemlink D, Plazzi G, Antelmi E, Biscarini F, Mollenhauer B, Trenkwalder C, Sixel-Doring F, Figorilli M, Puligheddu M, De Cock VC, Oertel W, Janzen A, Ferini-Strambi L, Heibreder A, Monaca CC, Abril B, Dijkstra F, Viaene M, Boeve BF, Postuma RB, Rouleau GA, Gan-Or Z (2023) NPC1 variants are not associated with Parkinson’s disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts. Neurobiol Aging 127:94–98PubMedCrossRef
go back to reference Soto M, Iranzo A, Lahoz S, Fernández M, Serradell M, Gaig C, Melón P, Martí MJ, Santamaría J, Camps J, Fernández-Santiago R, Ezquerra M (2022) Serum microRNAs predict isolated rapid eye movement sleep behavior disorder and Lewy body diseases. Mov Disord 37:2086–2098PubMedPubMedCentralCrossRef Soto M, Iranzo A, Lahoz S, Fernández M, Serradell M, Gaig C, Melón P, Martí MJ, Santamaría J, Camps J, Fernández-Santiago R, Ezquerra M (2022) Serum microRNAs predict isolated rapid eye movement sleep behavior disorder and Lewy body diseases. Mov Disord 37:2086–2098PubMedPubMedCentralCrossRef
go back to reference St Louis EK, Boeve AR, Boeve BF (2017) REM sleep behavior disorder in Parkinson’s disease and other synucleinopathies. Mov Disord 32:645–658PubMedCrossRef St Louis EK, Boeve AR, Boeve BF (2017) REM sleep behavior disorder in Parkinson’s disease and other synucleinopathies. Mov Disord 32:645–658PubMedCrossRef
go back to reference Steinbusch HWM, Dolatkhah MA, Hopkins DA (2021) Anatomical and neurochemical organization of the serotonergic system in the mammalian brain and in particular the involvement of the dorsal raphe nucleus in relation to neurological diseases. Prog Brain Res 261:41–81PubMedCrossRef Steinbusch HWM, Dolatkhah MA, Hopkins DA (2021) Anatomical and neurochemical organization of the serotonergic system in the mammalian brain and in particular the involvement of the dorsal raphe nucleus in relation to neurological diseases. Prog Brain Res 261:41–81PubMedCrossRef
go back to reference Stockbauer A, Beyer L, Huber M, Kreuzer A, Palleis C, Katzdobler S, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Lathuilière A, Lemstra AW, van Berckel BNM, Pilotto A, Padovani A, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Bauckneht M, Pardini M, Sambuceti G, Aarsland D, Nobili F, Gross M, Vöglein J, Perneczky R, Pogarell O, Buerger K, Franzmeier N, Danek A, Levin J, Höglinger GU, Bartenstein P, Cumming P, Rominger A, Brendel M (2024) Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. Eur J Nucl Med Mol Imaging 51:1023–1034PubMedCrossRef Stockbauer A, Beyer L, Huber M, Kreuzer A, Palleis C, Katzdobler S, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Lathuilière A, Lemstra AW, van Berckel BNM, Pilotto A, Padovani A, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Bauckneht M, Pardini M, Sambuceti G, Aarsland D, Nobili F, Gross M, Vöglein J, Perneczky R, Pogarell O, Buerger K, Franzmeier N, Danek A, Levin J, Höglinger GU, Bartenstein P, Cumming P, Rominger A, Brendel M (2024) Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. Eur J Nucl Med Mol Imaging 51:1023–1034PubMedCrossRef
go back to reference Tabata K, Saijo Y, Morikawa F, Naoe J, Yoshioka E, Kawanishi Y, Nakagi Y, Yoshida T (2017) Association of premorbid personality with behavioral and psychological symptoms in dementia with Lewy bodies: comparison with Alzheimer’s disease patients. Psychiatry Clin Neurosci 71:409–416PubMedCrossRef Tabata K, Saijo Y, Morikawa F, Naoe J, Yoshioka E, Kawanishi Y, Nakagi Y, Yoshida T (2017) Association of premorbid personality with behavioral and psychological symptoms in dementia with Lewy bodies: comparison with Alzheimer’s disease patients. Psychiatry Clin Neurosci 71:409–416PubMedCrossRef
go back to reference Takahashi H, Yoshida K, Sugita T, Higuchi H, Shimizu T (2003) Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series. Prog Neuropsychopharmacol Biol Psychiatry 27:549–553PubMedCrossRef Takahashi H, Yoshida K, Sugita T, Higuchi H, Shimizu T (2003) Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series. Prog Neuropsychopharmacol Biol Psychiatry 27:549–553PubMedCrossRef
go back to reference Terum TM, Testad I, Rongve A, Aarsland D, Svendsboe E, Andersen JR (2019) The association between specific neuropsychiatric disturbances in people with Alzheimer’s disease and dementia with Lewy bodies and carer distress. Int J Geriatr Psychiatry 34:1421–1428PubMedCrossRef Terum TM, Testad I, Rongve A, Aarsland D, Svendsboe E, Andersen JR (2019) The association between specific neuropsychiatric disturbances in people with Alzheimer’s disease and dementia with Lewy bodies and carer distress. Int J Geriatr Psychiatry 34:1421–1428PubMedCrossRef
go back to reference Turner RS (2002) Idiopathic rapid eye movement sleep behavior disorder is a harbinger of dementia with Lewy bodies. J Geriatr Psychiatry Neurol 15:195–199PubMedCrossRef Turner RS (2002) Idiopathic rapid eye movement sleep behavior disorder is a harbinger of dementia with Lewy bodies. J Geriatr Psychiatry Neurol 15:195–199PubMedCrossRef
go back to reference Turner RS, D’Amato CJ, Chervin RD, Blaivas M (2000) The pathology of REM sleep behavior disorder with comorbid Lewy body dementia. Neurology 55:1730–1732PubMedCrossRef Turner RS, D’Amato CJ, Chervin RD, Blaivas M (2000) The pathology of REM sleep behavior disorder with comorbid Lewy body dementia. Neurology 55:1730–1732PubMedCrossRef
go back to reference Vik-Mo AO, Giil LM, Ballard C, Aarsland D (2018) Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study. Int J Geriatr Psychiatry 33:1361–1369PubMedCrossRef Vik-Mo AO, Giil LM, Ballard C, Aarsland D (2018) Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study. Int J Geriatr Psychiatry 33:1361–1369PubMedCrossRef
go back to reference Visintin E, De Panfilis C, Antonucci C, Capecci C, Marchesi C, Sambataro F (2015) Parsing the intrinsic networks underlying attention: a resting state study. Behav Brain Res 278:315–322PubMedCrossRef Visintin E, De Panfilis C, Antonucci C, Capecci C, Marchesi C, Sambataro F (2015) Parsing the intrinsic networks underlying attention: a resting state study. Behav Brain Res 278:315–322PubMedCrossRef
go back to reference Watanabe H, Uchiyama M, Yokoi K, Mamiya Y, Narita W, Iizuka O, Baba T, Suzuki K, Mori E, Nishio Y (2023) Behavioral and neural correlates of pareidolic illusions in dementia with Lewy bodies. Parkinsonism Relat Disord 113:105513PubMedCrossRef Watanabe H, Uchiyama M, Yokoi K, Mamiya Y, Narita W, Iizuka O, Baba T, Suzuki K, Mori E, Nishio Y (2023) Behavioral and neural correlates of pareidolic illusions in dementia with Lewy bodies. Parkinsonism Relat Disord 113:105513PubMedCrossRef
go back to reference Watson R, Colloby SJ, Blamire AM, Wesnes KA, Wood J, O’Brien JT (2017) Does attentional dysfunction and thalamic atrophy predict decline in dementia with Lewy bodies? Parkinsonism Relat Disord 45:69–74PubMedCrossRef Watson R, Colloby SJ, Blamire AM, Wesnes KA, Wood J, O’Brien JT (2017) Does attentional dysfunction and thalamic atrophy predict decline in dementia with Lewy bodies? Parkinsonism Relat Disord 45:69–74PubMedCrossRef
go back to reference Wei H, Masurkar AV, Razavian N (2023) On gaps of clinical diagnosis of dementia subtypes: a study of Alzheimer’s disease and Lewy body disease. Front Aging Neurosci 15:1149036PubMedPubMedCentralCrossRef Wei H, Masurkar AV, Razavian N (2023) On gaps of clinical diagnosis of dementia subtypes: a study of Alzheimer’s disease and Lewy body disease. Front Aging Neurosci 15:1149036PubMedPubMedCentralCrossRef
go back to reference Weintraub D, Irwin D (2022) Diagnosis and treatment of cognitive and neuropsychiatric symptoms in Parkinson disease and dementia with Lewy bodies. Continuum (Minneap Minn) 28:1314–1332PubMed Weintraub D, Irwin D (2022) Diagnosis and treatment of cognitive and neuropsychiatric symptoms in Parkinson disease and dementia with Lewy bodies. Continuum (Minneap Minn) 28:1314–1332PubMed
go back to reference Williams D, Campbell K (2019) Electroconvulsive Therapy for the Treatment of the Behavioural and Psychological Symptoms of Dementia: A Review of Clinical Effectiveness and Guidelines, 2019/05/22 Edition. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. https://www.ncbi.nlm.nih.gov/books/NBK546016/ Williams D, Campbell K (2019) Electroconvulsive Therapy for the Treatment of the Behavioural and Psychological Symptoms of Dementia: A Review of Clinical Effectiveness and Guidelines, 2019/05/22 Edition. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK546016/​
go back to reference Wright LM, Donaghy PC, Burn DJ, Taylor JP, O’Brien JT, Yarnall AJ, Matthews FE, Firbank MJ, Thomas AJ, Lawson RA (2023) Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body dementia: a longitudinal study. Parkinsonism Relat Disord 113:105762PubMedCrossRef Wright LM, Donaghy PC, Burn DJ, Taylor JP, O’Brien JT, Yarnall AJ, Matthews FE, Firbank MJ, Thomas AJ, Lawson RA (2023) Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body dementia: a longitudinal study. Parkinsonism Relat Disord 113:105762PubMedCrossRef
go back to reference Yang J, Pourzinal D, Rheinberger T, Copland DA, McMahon KL, Byrne GJ, Dissanayaka NN (2022) The attention Network Test in Parkinson and Lewy body disease: a systematic review. Cogn Behav Neurol 35:1–13PubMedCrossRef Yang J, Pourzinal D, Rheinberger T, Copland DA, McMahon KL, Byrne GJ, Dissanayaka NN (2022) The attention Network Test in Parkinson and Lewy body disease: a systematic review. Cogn Behav Neurol 35:1–13PubMedCrossRef
go back to reference Yoshida T, Mori T, Yamazaki K, Sonobe N, Shimizu H, Matsumoto T, Kikuchi K, Miyagawa M, Mochizuki T, Ueno S (2015) Relationship between regional cerebral blood flow and neuropsychiatric symptoms in dementia with Lewy bodies. Int J Geriatr Psychiatry 30:1068–1075PubMedCrossRef Yoshida T, Mori T, Yamazaki K, Sonobe N, Shimizu H, Matsumoto T, Kikuchi K, Miyagawa M, Mochizuki T, Ueno S (2015) Relationship between regional cerebral blood flow and neuropsychiatric symptoms in dementia with Lewy bodies. Int J Geriatr Psychiatry 30:1068–1075PubMedCrossRef
go back to reference Yuan T, Zuo Z, Xu J (2023) Neuroanatomical localization of rapid eye movement sleep behavior disorder in human brain using lesion network mapping. Korean J Radiol 24:247–258PubMedPubMedCentralCrossRef Yuan T, Zuo Z, Xu J (2023) Neuroanatomical localization of rapid eye movement sleep behavior disorder in human brain using lesion network mapping. Korean J Radiol 24:247–258PubMedPubMedCentralCrossRef
go back to reference Yuuki S, Hashimoto M, Koyama A, Matsushita M, Ishikawa T, Fukuhara R, Honda K, Miyagawa Y, Ikeda M, Takebayashi M (2023) Comparison of caregiver burden between dementia with Lewy bodies and Alzheimer’s disease. Psychogeriatrics 23:682–689PubMedCrossRef Yuuki S, Hashimoto M, Koyama A, Matsushita M, Ishikawa T, Fukuhara R, Honda K, Miyagawa Y, Ikeda M, Takebayashi M (2023) Comparison of caregiver burden between dementia with Lewy bodies and Alzheimer’s disease. Psychogeriatrics 23:682–689PubMedCrossRef
go back to reference Zhang R, Li Z, Bai Y, Xu P, Zhang J, Zhang H (2020) [Changes of brain structural network properties in patients with rapid eye movement sleep behavior disorder]. Nan Fang Yi Ke Da Xue Xue Bao 40:125–130PubMed Zhang R, Li Z, Bai Y, Xu P, Zhang J, Zhang H (2020) [Changes of brain structural network properties in patients with rapid eye movement sleep behavior disorder]. Nan Fang Yi Ke Da Xue Xue Bao 40:125–130PubMed
go back to reference Zhu CW, Grossman HT, Elder GA, Rosen H, Sano M (2024) Apathy in Lewy body disease and its effects on functional impairment over time. Front Neurol 15:1339190PubMedPubMedCentralCrossRef Zhu CW, Grossman HT, Elder GA, Rosen H, Sano M (2024) Apathy in Lewy body disease and its effects on functional impairment over time. Front Neurol 15:1339190PubMedPubMedCentralCrossRef
Metadata
Title
Behavioral disorders in dementia with Lewy bodies: old and new knowledge
Author
Kurt A. Jellinger
Publication date
06-09-2024
Publisher
Springer Vienna
Published in
Journal of Neural Transmission
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-024-02823-w

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Learn more